However, there are a number of MAPs that differently express in each cancer type; for example, MAP2 upregulation was found in several types of carcinoma and myeloma, especially, and it was indicated as a potential tumor marker among neuronal epithelial tumor subtypes due to its limited expression in neurons. The gene discussed is C3orf62; the disease is neoplasm.